Skip to main content
Premium Trial:

Request an Annual Quote

Locus Pharmaceuticals Taps into IBM s Computing on Demand

NEW YORK, Dec. 2 (GenomeWeb News) - Locus Pharmaceuticals will use supercomputing power from IBM's Deep Computing Capacity on Demand center to support its drug discovery and development activities, IBM said today.

Locus will augment its existing 2.3 teraflop supercomputing infrastructure by tapping into an IBM eServer Linux cluster system located at IBM's on-demand center in Poughkeepsie, New York.

Jeff Wiseman, vice president of technology and informatics at Locus Pharmaceuticals, said that IBM's computer scientists worked with the company to optimize its proprietary drug-design algorithms for the on-demand computing environment.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.